Diffuse Skeletal Muscle F-18 Fluorodeoxyglucose Uptake in Advanced Primary Muscle Non-Hodgkin's Lymphoma

Clinical Nuclear Medicine

Volumn 34, Issue 4, 2009, Pages 251-253

  Broski, Stephen M ^a   Bou Assaly, Wessam B ^a,b   Gross, Milton D ^a,b   Fig, Lorraine M ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VAAAHS   (United States)

Author keywords

FDG; PET; Primary muscle lymphoma; Skeletal muscle uptake

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

AGED; ARTICLE; BONE MARROW BIOPSY; CANCER STAGING; CASE REPORT; COMPRESSION FRACTURE; DRUG UPTAKE; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; MALE; MUSCLE CONTRACTION; MUSCLE DISEASE; MUSCLE HYPERTROPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; SKELETAL MUSCLE; TUMOR BIOPSY;

AGED; DISEASE PROGRESSION; FATAL OUTCOME; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MUSCLE NEOPLASMS; MUSCLE, SKELETAL; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 67650647167     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e31819a2020     Document Type: Article

References (22)

1. Glass AG, Karnell LH, Menck HR. The National Cancer Data Base report on non-Hodgkin's lymphoma. Cancer. 1997;80:2311-2320.
2. Rosenberg SA, Diamond HD, Jaslowitz B, et al. Lymphosarcoma: a review of 1296 cases. Medicine. 1966;40:31-84.
3. Jeffery GM, Golding PF, Mead GM. Non-Hodgkin's lymphoma arising in skeletal muscle. Ann Oncol. 1991;2:501-504.
4. Lanham GR, Weiss SW, Enzinger FM. Malignant lymphoma. A study of 75 cases presenting in soft tissue. Am J Surg Pathol. 1989;13:1-10.
5. Lee VS, Martinez S, Coleman RE. Primary muscle lymphoma: clinical and imaging findings. Radiology. 1997;203:237-244.
6. Chim CS, Choy C, Liang R. Primary anaplastic large cell lymphoma of skeletal muscle presenting with compartment syndrome. Leuk Lymphoma. 1999;33:601-605.
7. Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics. 1999;19:61-77.
8. Engel H, Steinert H, Buck A, et al. Whole-body PET: physiological and artifactual fluorodeoxyglucose accumulations. J Nucl Med. 1996;37:441-446.
9. Cook GJ, Wegner EA, Fogelman I. Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging. Semin Nucl Med. 2004;34:122-133.
10. Cook GJ, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation. Semin Nucl Med. 1996;26:308-314.
11. Tashiro M, Fujimoto T, Itoh M, et al. 18F-FDG PET imaging of muscle activity in runners. J Nucl Med. 1999;40:70 -76.
12. Yasuda S, Fujii H, Takahashi W, et al. Elevated F-18 FDG uptake in the psoas muscle. Clin Nucl Med. 1998;23:716-717.
13. Yasuda S, Ide M, Takagi S, et al. Elevated F-18 FDG uptake in skeletal muscle. Clin Nucl Med. 1998;23:111-112.
14. Bar-Shalom R. Muscle uptake of 18-fluorine fluorodeoxyglucose. Semin Nucl Med. 2000;30:306-309.
15. Gradinscak DJ, Fulham MJ, Mohamed A, et al. Skeletal muscle uptake detected on FDG PET 48 hours after exertion. Clin Nucl Med. 2003;28:840 -841.
16. Barrington SF, Maisey MN. Skeletal uptake of fluorine-18-FDG: effect of oral diazepam. J Nucl Med. 1996;37:1127-1129.
17. Bural GG, Mavi A, Kumar R, et al. FDG uptake in intercostal muscles is an indicator of severe respiratory disease. Clin Nucl Med. 2004;29:807-808.
18. Aydin A, Hickeson M, Yu JQ, et al. Demonstration of excessive metabolic activity of thoracic and abdominal muscles on FDG-PET in patients with chronic obstructive pulmonary disease. Clin Nucl Med. 2005;30:159-164.
19. Abdel-Dayem HM, Naddaf S, El-Zeftawy H. F-18 FDG gastric and anterior abdominal muscle uptake secondary to nausea and vomiting. Clin Nucl Med. 1998;23:769-770.
20. Ojha B, Muthukrishnan A, Raman AK, et al. Diffuse F-18 FDG uptake in skeletal muscles secondary to chills resulting from sepsis: a cause for underestimation of viable tumor. Clin Nucl Med. 2004;29:600-601.
21. Bakheet S, Powe J. Benign causes of 18-FDG uptake on whole body imaging. Semin Nucl Med. 1998;28:352-358.
22. Kaim AH, Weber B, Kurrer MO, et al. (18)F-FDG and (18)F-FET uptake in experimental soft tissue infection. Eur J Nucl Med Mol Imaging. 2002;29: 648-654.